Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    22465047 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome
Condition: Fibromyalgia
Interventions: Drug: Saizen®;   Drug: Placebo and Saizen®
To Top

† Indicates status has not been verified in more than two years